Should I buy Nike, Inc. (NKE) stock or is it too late?
⭐ The most reliable of them, either direction: UBS — 68% of its targets hit on this sector (485 calls tested). It aims for $34 (-3.8 %), call made on October 3, 2026, maturing on October 3, 2027 (11 d ago).
Firm-by-firm track record on Nike, Inc.
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| HSBC | 100 % | +15.8 % | 5 | $162 +359% |
| UBS | 68 % | +15.8 % | 25 | $34 -4% |
| Citigroup | 58 % | +12.4 % | 19 | $32 -9% |
| BTIG | 60 % | +11.5 % | 5 | $50 +42% |
| Stifel | 50 % | +5.2 % | 32 | $36 +2% |
| Morgan Stanley | 48 % | +4.3 % | 42 | $27 -24% |
| Argus Research | 62 % | +3.3 % | 8 | $85 +141% |
| Barclays | 46 % | +3.2 % | 13 | $37 +5% |
✅ Reasons to believe
- Pays a dividend (3.8% yield), raised for 9 years — regular income on top of potential upside.
- Reasonable valuation (P/E ~17) relative to its sector.
⚠️ Reasons to hesitate
- Even the most reliable firm on NKE, UBS (68% hit rate, 25 scored calls), only targets $34 (call made on October 2, 2026, maturing on October 2, 2027) (-4%) in its most recent call, and $48 (call made on July 1, 2026, maturing on July 1, 2027) (+36%) in the one coming due soonest. The stock may already have run past its target.
- The consensus is not unanimous: of 27 ratings, 15 are neutral and 5 are sells.
- Limited upside: the median target is only -2% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
The analyst consensus on NKE
Median target $35 (-2%) · 27 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Nike, Inc. now?
We won't decide for you. The facts: 26% of analysts rate it a buy, median target $35 (-2%), and UBS (most reliable on NKE, 68%) targets $34. Weigh that against valuation (P/E ~17) and volatility. This is not personalized advice.
Is it too late to invest in Nike, Inc.?
The stated upside is small: the median target ($35) sits just -2% from the price ($35) (most reliable on NKE: UBS, 68%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Nike, Inc. still worth investing in?
It depends on the gap between the price ($35) and its estimated value: analysts target $35 on median (-2%), with 26% buys (most reliable on NKE: UBS, 68%). Cross-check with their real reliability on NKE and the cautions above. Information, not advice.
What's the main risk in buying NKE?
Even the most reliable firm on NKE, UBS (68% hit rate, 25 scored calls), only targets $34 (call made on October 2, 2026, maturing on October 2, 2027) (-4%) in its most recent call, and $48 (call made on July 1, 2026, maturing on July 1, 2027) (+36%) in the one coming due soonest. The stock may already have run past its target.
→ Go deeper: the full Nike, Inc. profile (consensus, analyst reliability, price target, performance).